Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • SAVIENT PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: SVNT

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.111 Buy 9
    30 Days Ago 2.111 Buy 9
    60 Days Ago 2.333 Buy 9
    90 Days Ago 2.333 Buy 9
    120 Days Ago 1.889 Buy 9

  • Analyst Ratings: SVNT

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Oppenheimer Perform Outperform 10/08/2009 17.00
    Leerink Swann — Outperform 09/16/2009 18.00
    Jefferies & Co Hold Underperform 08/03/2009 5.00
    JMP Securities — Mkt Outperform 06/17/2009 15.00
    Oppenheimer Underperform Perform 06/16/2009 —
    Wall Street Access Hold Buy 06/15/2009 13.00
    Wedbush Morgan — Buy 06/10/2009 15.00
    Roth Capital — Buy 12/19/2008 7.00
    Leerink Swann — Outperform 11/25/2008 13.00
    Oppenheimer Perform Underperform 11/25/2008 —
    Cowen & Co Outperform Underperform 10/27/2008 —
    Collins Stewart — Buy 10/20/2008 25.00
    Jefferies & Co — Hold 09/16/2008 19.00
    Oppenheimer — Perform 09/11/2008 —
    Jefferies & Co Buy Hold 08/04/2008 25.00
    Dawson James — Buy 06/23/2008 30.00
    Jefferies & Co — Buy 04/01/2008 30.00
    Lazard Capital — Buy 01/10/2008 29.00
    Dawson James — Buy 12/13/2007 21.50
    Citigroup — Buy 11/28/2007 21.00
    Credit Suisse — Outperform 10/03/2007 23.00
    Cowen & Co — Outperform 09/21/2007 —
    Ferris Baker Watts — Buy 03/29/2007 18.00
    Lazard Capital — Buy 02/01/2007 22.00
    HC Wainwright Neutral Sell 10/25/2006 6.90